Delve into the growing cat-focused biotech landscape. Cats are the second most adopted pets and biotech is making their lives ...

Discover how melanoma vaccines are gaining traction in the clinic and could soon become a treatment option for this deadly ...

Discover six of the top psychedelic companies developing novel drugs to expand the treatment scope for mental health ...

Discover why some biotechs fail but survive with cash on hand, and how players like Concentra are trying to unlock trapped ...

Learn about July 2025’s top biotech deals, featuring major collaborations in small molecules, antibodies, and drug delivery.

Abivax, MapLight Therapeutics, Everest Medicines, and Soleno Therapeutics bagged the biggest biotech funding rounds overall ...

This past year has seen various developments in the field of oncolytic virus therapies - in fundraising and in the clinic.

Five acquisitions in 2025—including Cargo and Allakos—have put Concentra Biosciences in the spotlight. Learn what’s behind the strategy.

Find out if Novo's GLP-1 patent expiring in Canada is a mistake or a calculated move. Did the firm lose exclusivity over a small fee?

Discover the new migraine medications, such as monoclonal antibodies and gepants, that are changing migraine treatment for the better.